These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 18182779)
21. Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies. Mollenhauer B; El-Agnaf OM; Marcus K; Trenkwalder C; Schlossmacher MG Biomark Med; 2010 Oct; 4(5):683-99. PubMed ID: 20945981 [TBL] [Abstract][Full Text] [Related]
22. Controlling the mass action of alpha-synuclein in Parkinson's disease. Kim C; Lee SJ J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382 [TBL] [Abstract][Full Text] [Related]
23. Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour. George S; van den Buuse M; San Mok S; Masters CL; Li QX; Culvenor JG Exp Neurol; 2008 Apr; 210(2):788-92. PubMed ID: 18295208 [TBL] [Abstract][Full Text] [Related]
24. beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein. Kim YS; Lim D; Kim JY; Kang SJ; Kim YH; Im H Biochem Biophys Res Commun; 2009 Oct; 387(4):682-7. PubMed ID: 19622344 [TBL] [Abstract][Full Text] [Related]
25. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein. Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219 [TBL] [Abstract][Full Text] [Related]
26. Capillary microsampling and analysis of 4-µl blood, plasma and serum samples to determine human α-synuclein elimination rate in mice. Jonsson O; Steffen AC; Sundquist VS; Janson J; Martinsson S; Määttä U; Emanuelsson AB Bioanalysis; 2013 Feb; 5(4):449-62. PubMed ID: 23414378 [TBL] [Abstract][Full Text] [Related]
27. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-alpha,beta on monocytes from patients with warm autoimmune hemolytic anemia. Barros MM; Yamamoto M; Figueiredo MS; Cançado R; Kimura EY; Langhi DM; Chiattone CS; Bordin JO Transfusion; 2009 Jan; 49(1):154-60. PubMed ID: 18954403 [TBL] [Abstract][Full Text] [Related]
28. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease. Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095 [TBL] [Abstract][Full Text] [Related]
30. Alpha-synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells. Wu F; Poon WS; Lu G; Wang A; Meng H; Feng L; Li Z; Liu S Brain Res; 2009 Oct; 1292():173-9. PubMed ID: 19646423 [TBL] [Abstract][Full Text] [Related]
31. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Parihar MS; Parihar A; Fujita M; Hashimoto M; Ghafourifar P Int J Biochem Cell Biol; 2009 Oct; 41(10):2015-24. PubMed ID: 19460457 [TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation. Shaikh S; Nicholson LF J Neurosci Res; 2008 Jul; 86(9):2071-82. PubMed ID: 18335520 [TBL] [Abstract][Full Text] [Related]
33. alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells. Kazmierczak A; Strosznajder JB; Adamczyk A Neurochem Int; 2008 Dec; 53(6-8):263-9. PubMed ID: 18804502 [TBL] [Abstract][Full Text] [Related]
34. Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology. Ikeda M; Kawarabayashi T; Harigaya Y; Sasaki A; Yamada S; Matsubara E; Murakami T; Tanaka Y; Kurata T; Wuhua X; Ueda K; Kuribara H; Ikarashi Y; Nakazato Y; Okamoto K; Abe K; Shoji M Brain Res; 2009 Jan; 1250():232-41. PubMed ID: 18992718 [TBL] [Abstract][Full Text] [Related]
36. A comparative study of the amount of α-synuclein in ischemic stroke and Parkinson's disease. Zhao HQ; Li FF; Wang Z; Wang XM; Feng T Neurol Sci; 2016 May; 37(5):749-54. PubMed ID: 26829934 [TBL] [Abstract][Full Text] [Related]
37. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP. Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162 [TBL] [Abstract][Full Text] [Related]
38. Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus? Puschmann A; Wszolek ZK; Farrer M; Gustafson L; Widner H; Nilsson C Parkinsonism Relat Disord; 2009 Jun; 15(5):390-2. PubMed ID: 18824390 [TBL] [Abstract][Full Text] [Related]
39. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease. Park JY; Paik SR; Jou I; Park SM Glia; 2008 Aug; 56(11):1215-23. PubMed ID: 18449945 [TBL] [Abstract][Full Text] [Related]
40. Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells. Klongpanichapak S; Phansuwan-Pujito P; Ebadi M; Govitrapong P Neurosci Lett; 2008 May; 436(3):309-13. PubMed ID: 18406059 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]